Overview of Biosimilars for Immune-Mediated Inflammatory Diseases: Summary of Current Evidence

Patents and Legal Issues. The Biologics Price Competition and Innovation Act (BPCIA, 2010), part of the Patient Protection and Affordable Care Act,was …